TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2252771

Group type: EXPERIMENTAL
Intervention: 2 hr HD with high blood flow
Number of subjects: 23

Group type: COMPARATOR
Intervention: 4 hr HD with slow blood flow
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Ultrafiltration volume
Number of subjects: 23

Group type: COMPARATOR
Intervention: Type of membrane (Cuprophan, Hemophan, Polyamide)
Number of subjects: 23
Study: 6999128

Group type: EXPERIMENTAL
Intervention: Choline chloride
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 14
Study: 31425577

Group type: EXPERIMENTAL
Intervention: Testosterone gel treatment for 6 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo gel treatment for 6 weeks
Number of subjects: 45
Study: 29800234

Group type: EXPERIMENTAL
Intervention: ReCell® Autologous Cell Harvesting Device (ASCS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Meshed split-thickness skin grafts (STSG)
Number of subjects: 100
Study: 28558718

Group type: EXPERIMENTAL
Intervention: Lactic-fermented egg white (LE) with 8 g of protein daily for 8 weeks
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Lactic-fermented egg white (LE) with 4 g of protein daily for 8 weeks
Number of subjects: 88
Study: 26180474

Group type: EXPERIMENTAL
Intervention: Corneal collagen cross-linking (CXL) with riboflavin drops and ultraviolet radiation
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (contralateral eye)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Corneal collagen cross-linking (CXL)
Number of subjects: 26
Study: 23869655

Group type: EXPERIMENTAL
Intervention: Intravenous lipid emulsion (ILE)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Supportive care (Control)
Number of subjects: 64
Study: 23450080

Group type: EXPERIMENTAL
Intervention: Family-centered empowerment model
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 86
Study: 18978628

Group type: EXPERIMENTAL
Intervention: Intensive combined training program (10 weeks, 4 times a week)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Technical training (control group)
Number of subjects: 24
Study: 17165503

Group type: EXPERIMENTAL
Intervention: Turtle-probing needling at Tianzhu (BL 10)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine needling at Fengchi (GB 20), Tianzhu (BL 10), Shuaigu (GB 8), Touwei (ST 8), and corresponding cervical Jiaji points (EX-B2), Houxi (SI 3), Ashi points
Number of subjects: 70
Study: 12715585

Group type: EXPERIMENTAL
Intervention: Reflexology (6 sessions of 30 minutes each)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Reflexology
Number of subjects: 50
Study: 10884634

Group type: EXPERIMENTAL
Intervention: Salt and soda mouthwash
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthwash
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Magic mouthwash (lidocaine, Benadryl, and Maalox)
Number of subjects: 200
Study: 9226551

Group type: EXPERIMENTAL
Intervention: Ordinary capillary‐zone electrophoresis (CZE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SDS‐CZE
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CIEF
Number of subjects: 0
Study: 8080420

Group type: EXPERIMENTAL
Intervention: 0.05% tretinoin cream
Number of subjects: 28

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 28
Study: 2890520

Group type: EXPERIMENTAL
Intervention: Atenolol (beta 1)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Oxprenolol (beta 1/2)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Atenolol vs Oxprenolol
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Oxprenolol
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 9
Study: 29325967

Group type: EXPERIMENTAL
Intervention: Abdominal binder
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no binder)
Number of subjects: 90
Study: 27602968

Group type: EXPERIMENTAL
Intervention: Microneedling followed by Levulan PDT
Number of subjects: 20

Group type: COMPARATOR
Intervention: PDT alone (Levulan without microneedling)
Number of subjects: 20
Study: 24243316

Group type: EXPERIMENTAL
Intervention: Tigecycline 50 mg q12h
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 22445776

Group type: EXPERIMENTAL
Intervention: GSK598809 (dopamine D3 receptor antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 19837118

Group type: EXPERIMENTAL
Intervention: Wholegrain wheat bread (WWB)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Refined wheat pasta (RWP)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Wholegrain wheat pasta (WWP)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Refined wheat bread (RWB)
Number of subjects: 16
Study: 18455203

Group type: EXPERIMENTAL
Intervention: Visual cues indicating object weight
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Auditory cues indicating object weight
Number of subjects: 0

Group type: COMPARATOR
Intervention: No cue about the weight of the object
Number of subjects: 0
Study: 16020820

Group type: EXPERIMENTAL
Intervention: Involuntary psychiatric examinations initiated by law enforcement officials
Number of subjects: 130
Study: 11960044

Group type: EXPERIMENTAL
Intervention: Transperitoneal laparoscopic retropubic urethropexy using nonabsorbable sutures (group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Transperitoneal laparoscopic retropubic urethropexy using polypropylene mesh fixed with tacks or staples (group B)
Number of subjects: 60
Study: 9822993

Group type: EXPERIMENTAL
Intervention: Oral psychotropic medications with clubhouse program attendance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Injectable neuroleptic regimens with clubhouse program attendance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychosocial rehabilitation clubhouses
Number of subjects: 0
Study: 8107739

Group type: EXPERIMENTAL
Intervention: High-dose methylprednisolone (15 mg/kg, max 1000 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 36
Study: 2779692

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (2 mg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (3 mg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Prednisolone sodium phosphate (30 mg)
Number of subjects: 23
Study: 787960

Group type: EXPERIMENTAL
Intervention: Dicyclomine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7029838

Group type: EXPERIMENTAL
Intervention: SHRZ/HRZ (6 months)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: SHRZ/HR (6 months)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: SHRZ/HRZ (4 months)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: SHRZ/HR (4 months)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Bacilli resistant to isoniazid or streptomycin (6 months)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Bacilli resistant to isoniazid or streptomycin (4 months)
Number of subjects: 330
Study: 31397077

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics (single dose prior to surgery)
Number of subjects: 206

Group type: COMPARATOR
Intervention: No prophylactic antibiotics (no preoperative and postoperative antibiotics)
Number of subjects: 206
Study: 28010953

Group type: EXPERIMENTAL
Intervention: Pravastatin (10 mg daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No statins (control group)
Number of subjects: 0
Study: 26070226

Group type: EXPERIMENTAL
Intervention: Hysteroscopic-guided pertubal diluted bupivacaine infusion (0.25%)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 24605899

Group type: EXPERIMENTAL
Intervention: Metformin 1,500 mg daily
Number of subjects: 35
Study: 22622912

Group type: EXPERIMENTAL
Intervention: Transforaminal epidural injections with local anesthetic and steroids
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Local anesthetics alone
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Local anesthetic with or without steroids
Number of subjects: 27
Study: 19211170

Group type: EXPERIMENTAL
Intervention: 70 J/cm2 UVA1 phototherapy
Number of subjects: 16

Group type: COMPARATOR
Intervention: 20 J/cm2 UVA1 phototherapy
Number of subjects: 16

Group type: COMPARATOR
Intervention: No irradiation (control)
Number of subjects: 16
Study: 17405163

Group type: EXPERIMENTAL
Intervention: Maternal caffeine consumption (moderate intake)
Number of subjects: 4196

Group type: EXPERIMENTAL
Intervention: Maternal caffeine consumption (high intake)
Number of subjects: 4196

Group type: EXPERIMENTAL
Intervention: Coffee intake
Number of subjects: 4196

Group type: COMPARATOR
Intervention: Control group (no caffeine consumption)
Number of subjects: 4196
Study: 15345731

Group type: EXPERIMENTAL
Intervention: Bioelectrical Impedance Analysis (BIA) measuring intracellular water (ICW), extracellular water (ECW), and total body water (TBW) on four occasions (baseline, days 7, 14, and 28)
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Blood urea nitrogen/creatinine ratios greater than 21:1
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Delirium measured with NEECHAM Confusion Scale, Vigilance score, Mini-Mental Status Examination, and Confusion Assessment Method
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: BIA measures
Number of subjects: 313
Study: 11933032

Group type: EXPERIMENTAL
Intervention: Selection modelling framework
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pattern-mixture models
Number of subjects: 0
Study: 9701186

Group type: EXPERIMENTAL
Intervention: High-Carbohydrate (HC) diet for 16 days
Number of subjects: 25

Group type: COMPARATOR
Intervention: High-Fat (HF) diet for 16 days
Number of subjects: 25
Study: 7917149

Group type: EXPERIMENTAL
Intervention: Verapamil (180 to 480 mg/day)
Number of subjects: 15
Study: 2668133

Group type: EXPERIMENTAL
Intervention: IOL with a laser ridge
Number of subjects: 100

Group type: COMPARATOR
Intervention: IOL without a laser ridge
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 1199816

Group type: EXPERIMENTAL
Intervention: L-dopa administered as a solution
Number of subjects: 20

Group type: COMPARATOR
Intervention: L-dopa administered in tablet form
Number of subjects: 20

Group type: COMPARATOR
Intervention: Isocaloric meals (rich in protein or carbohydrate)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: L-dopa administered at short intervals
Number of subjects: 20
Study: 30244489

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided intercostal nerve block
Number of subjects: 38

Group type: COMPARATOR
Intervention: Fluoroscopy-guided epidural nerve block
Number of subjects: 38
Study: 28870648

Group type: EXPERIMENTAL
Intervention: Electromagnetic navigation system for maxillary repositioning
Number of subjects: 5

Group type: COMPARATOR
Intervention: Splint transposed control group
Number of subjects: 5
Study: 24750359

Group type: EXPERIMENTAL
Intervention: Simulated 24‐h international travel (INT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control trial (CON)
Number of subjects: 10
Study: 24459762

Group type: EXPERIMENTAL
Intervention: Minimally invasive thyroidectomy (MIT)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Minimally invasive video-assisted thyroidectomy (MIVAT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Both MIT and MIVAT
Number of subjects: 48
Study: 22196471

Group type: EXPERIMENTAL
Intervention: Nasal Cannula (NC; 0.5 L/kg/min)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Nasal Prongs with Continuous Positive Airway Pressure (NP-CPAP; 5-10 L/min, pressure 5 cmH(2)O)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Nasopharyngeal Catheter (NPC; 0.3-0.5 L/kg/min)
Number of subjects: 75
Study: 19193738

Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CsA)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Rapamycin
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (no immunosuppressive treatment)
Number of subjects: 28
Study: 17530971

Group type: EXPERIMENTAL
Intervention: Resistance exercise performed 14 hours before carbohydrate ingestion
Number of subjects: 10

Group type: COMPARATOR
Intervention: No exercise (control)
Number of subjects: 10
Study: 15195855

Group type: EXPERIMENTAL
Intervention: Rabeprazole sodium (20 mg single dose)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard reference preparation
Number of subjects: 12
Study: 12494116

Group type: EXPERIMENTAL
Intervention: Angiotensin converting enzyme inhibitors (ACEI)
Number of subjects: 0
Study: 9798440

Group type: EXPERIMENTAL
Intervention: 200 IU nasal salmon calcitonin (sCT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 8598260

Group type: EXPERIMENTAL
Intervention: Cisapride (10 mg orally every 8 hours)
Number of subjects: 51
Study: 2758767

Group type: EXPERIMENTAL
Intervention: 250HD3 (35 mcg/day for 25 days/month)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 337983

Group type: EXPERIMENTAL
Intervention: Nefopam 15 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Pethidine 50 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Pethidine 100 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nefopam 30 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nefopam
Number of subjects: 100

Group type: COMPARATOR
Intervention: Pethidine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 100
Study: 30543350

Group type: EXPERIMENTAL
Intervention: Immediate cytoreductive nephrectomy (CN) followed by sunitinib therapy
Number of subjects: 99

Group type: COMPARATOR
Intervention: Deferred CN after 3 cycles of sunitinib therapy
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Sunitinib therapy
Number of subjects: 99

Group type: COMPARATOR
Intervention: Immediate CN
Number of subjects: 99

Group type: COMPARATOR
Intervention: Deferred CN
Number of subjects: 99
Study: 27213285

Group type: EXPERIMENTAL
Intervention: Midvastus approach
Number of subjects: 52

Group type: COMPARATOR
Intervention: Medial parapatellar approach
Number of subjects: 52
Study: 26622035

Group type: EXPERIMENTAL
Intervention: Safety culture questionnaire with a complementary workshop
Number of subjects: 30

Group type: COMPARATOR
Intervention: Safety culture questionnaire alone
Number of subjects: 30
Study: 23384799

Group type: EXPERIMENTAL
Intervention: External beam radiotherapy (EBRT) delivering 55 Gy in 20 fractions
Number of subjects: 216

Group type: COMPARATOR
Intervention: External beam radiotherapy (EBRT) followed by high dose rate (HDR) brachytherapy of 2 × 8.5 Gy
Number of subjects: 216
Study: 21373871

Group type: EXPERIMENTAL
Intervention: Mixed diet with sprint training
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Vegetarian diet with sprint training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both groups (mixed and vegetarian diet) with sprint training
Number of subjects: 20
Study: 18985628

Group type: EXPERIMENTAL
Intervention: Gaboxadol 10 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Flurazepam 30 mg (positive control)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 17894827

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg daily
Number of subjects: 2838

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2838
Study: 15319390

Group type: EXPERIMENTAL
Intervention: CD56(dim)CD16(+)CD69(+) NK cells count >1.0 x 10(6)/l
Number of subjects: 138

Group type: COMPARATOR
Intervention: CD56(dim)CD16(+)CD69(+) NK cells count <1.0 x 10(6)/l
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Successful ongoing pregnancy
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Failed pregnancy
Number of subjects: 138
Study: 11417983

Group type: EXPERIMENTAL
Intervention: Breast-conserving surgery
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Mastectomy
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Adjuvant therapy (radiotherapy, tamoxifen)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Mammographic nipple to lesion distance <40 mm
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: High/intermediate nuclear grade
Number of subjects: 220
Study: 10168033

Group type: EXPERIMENTAL
Intervention: Autologous peripheral blood progenitor-cell transplantation (PBPCT)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Autologous bone marrow transplantation (BMT)
Number of subjects: 129
Study: 8485272

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lansoprazole 60 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg and 60 mg
Number of subjects: 12
Study: 3687892

Group type: EXPERIMENTAL
Intervention: Methadone for 2 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.4 mg naloxone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30213452

Group type: EXPERIMENTAL
Intervention: Camrelizumab monotherapy (1 mg/kg, 3 mg/kg, 10 mg/kg, and 200 mg every 2 weeks)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Camrelizumab 200 mg (day 1), gemcitabine 1 g/m2 (days 1 and 8), and cisplatin 80 mg/m2 (day 1) every 3 weeks followed by camrelizumab 200 mg maintenance once every 3 weeks
Number of subjects: 93
Study: 26548879

Group type: COMPARATOR
Intervention: 3 daily denture brushings using water at ambient temperature
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 3 daily denture brushings using water at ambient temperature plus coconut soap
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 3 daily denture brushings using water at ambient temperature plus dentifrice
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 3 daily denture brushings using water at ambient temperature combined with immersion in sodium perborate solution for 5 minutes before nocturnal sleep
Number of subjects: 20
Study: 24573942

Group type: EXPERIMENTAL
Intervention: Addison's disease patients
Number of subjects: 27

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Addison's disease patients with longer duration of illness
Number of subjects: 27
Study: 21752570

Group type: EXPERIMENTAL
Intervention: Narrative statement plus graphic element (speedometer metaphor or pictograph)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Narrative statement alone
Number of subjects: 182
Study: 20382273

Group type: EXPERIMENTAL
Intervention: Intervention group (N=1464)
Number of subjects: 2839

Group type: COMPARATOR
Intervention: Non-Intervention group (N=372)
Number of subjects: 2839

Group type: COMPARATOR
Intervention: No Risk Factors group (N=1003)
Number of subjects: 2839
Study: 17908705

Group type: EXPERIMENTAL
Intervention: n‐CPAP
Number of subjects: 52

Group type: COMPARATOR
Intervention: n‐IPPV
Number of subjects: 52
Study: 16051891

Group type: EXPERIMENTAL
Intervention: Simvastatin (80 mg daily)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 12103384

Group type: EXPERIMENTAL
Intervention: OPCAB (off-pump coronary artery bypass)
Number of subjects: 40

Group type: COMPARATOR
Intervention: ONCAB (on-pump coronary artery bypass)
Number of subjects: 40
Study: 11072391

Group type: EXPERIMENTAL
Intervention: Health care provider prompting intervention with tailored print communications
Number of subjects: 160

Group type: COMPARATOR
Intervention: Health care provider prompting intervention alone
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Health care provider prompting intervention with tailored print communications and tailored telephone counseling
Number of subjects: 160

Group type: COMPARATOR
Intervention: Provider intervention alone
Number of subjects: 160
Study: 7476052

Group type: EXPERIMENTAL
Intervention: 50 mg.d-1 iron supplement, low iron diet
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Placebo, free choice diet
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Meat supplement to achieve 15 mg.d-1 iron intake
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control, free choice diet
Number of subjects: 62
Study: 1417014

Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg tablet administered orally once at 2 hrs prior to cisplatin administration.
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo (lactose tablet) administered orally once at 2 hrs prior to cisplatin administration.
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Rescue medication with ondansetron injection if satisfactory anti-emetic effects were not obtained.
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Rescue medication with ondansetron injection.
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Side effects observed after rescue medication with ondansetron injection.
Number of subjects: 85
Study: 3886743

Group type: EXPERIMENTAL
Intervention: Intracoronary streptokinase
Number of subjects: 83

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 83
Study: 30410934

Group type: EXPERIMENTAL
Intervention: 0.20% Chlorhexidine gel (Plak ®Gel; Polifarma Wellness Srl, Rome, Italy)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo gel (Placebo, Polifarma Wellness Srl, Rome, Italy)
Number of subjects: 32
Study: 27082008

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral intervention designed to improve medication adherence and pain-related outcomes
Number of subjects: 110

Group type: COMPARATOR
Intervention: Provider assessments using the Aberrant Behavior Checklist (ABC)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Provider reports of AMTB
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: ABC ratings of experienced providers (nurse practitioners/attending physicians)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Associations between patient‐ and provider‐reported AMTB and urine drug screening results
Number of subjects: 110
Study: 26282661

Group type: EXPERIMENTAL
Intervention: Continuous Therapy (CT)
Number of subjects: 1218

Group type: COMPARATOR
Intervention: Fixed Duration Therapy (FDT)
Number of subjects: 1218
Study: 24148851

Group type: EXPERIMENTAL
Intervention: Decision aid prior to specialist consultation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 80
Study: 21160317

Group type: EXPERIMENTAL
Intervention: Stapled transanal rectal resection with a new, curved multifire stapler (TRANSTAR group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Stapled transanal rectal resection with 2 traditional circular staplers (STARR group)
Number of subjects: 100